A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is
Brain hypoxia-ischemia is a human neonatal injury that is considered a candidate for stem cell therapy. Methods: The possible therapeutic potential of human umbilical cord blood (HUCB) stem cells was evaluated in 14-day-old rats subjected to the right common carotid occlusion, a model of neonatal brain hypoxiaischemia. Seven days after hypoxia-ischemia, rats received either saline solution or 4 × 10 5 HUCB cells i.v. Rats in control group did not receive any injection. After two weeks, ratsdoi:10.6091/ibj.1376.2015 fatcat:xus3rah5tjhzbo3xr737qqs6ji